RigImmune
HOME RIGImmune - RIGImmune Inc.
United States · Founded 2020 · $3.5M raised
- Employees
- 1–10
- Founded
- 2020
- Website
- rigimmune.com
- Total Funding
- $3.5M
- Last Round
- $3.5M GrantJan 2023
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.
About
Yale-spinout biopharmaceutical company developing RNA immunotherapies targeting the RIG-I innate immune pathway for viral diseases and cancer.
Summary
RigImmune is a Biotech company based in United States, founded in 2020. It has raised $3.5M in total across 2 rounds, most recently a $3.5M Grant round in Jan 2023. Investors include Bill & Melinda Gates Foundation and F-Prime Capital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
2023 (est.)
Sign up to see all 2 events
Funding: Seed through Grant. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/rigimmune"><img src="https://indexed.vc/api/badge/company/rigimmune" alt="RigImmune on Indexed.vc" width="260" height="76" /></a>